Literature DB >> 20559845

Abnormalities of cerebral arteries are frequent in patients with late-onset Pompe disease.

Sabrina Sacconi1, Jonathan D Bocquet, Stéphane Chanalet, Véronique Tanant, Leonardo Salviati, Claude Desnuelle.   

Abstract

Cerebral aneurysms and arteropathies causing severe cerebrovascular events have been reported as rare complications in patients with late-onset Pompe disease. We investigated the frequency of cerebrovascular anomalies in six patients with late-onset Pompe disease followed at our institution. Clinical data collection and magnetic resonance angiography were performed as part of routine annual examinations. Four out of six patients had brain vascular anomalies including dolichoectasia of the basilar artery and ectasia of internal carotids. These patients also complained of gastrointestinal symptoms (chronic constipation and gastrointestinal reflux). Two patients had clinical signs related to the arteriopathy, including partial paralysis of the third cranial nerve and transient ischemic attacks. At 1 year follow-up, enzyme replacement therapy did not modify the size of cerebral vessels, but patients reported a marked improvement of intestinal symptoms. In conclusion, neurologists should be aware that intracranial artery abnormalities are not infrequent in patients with late-onset Pompe disease, and they should be specifically investigated in the presence of unexplained CNS symptoms.

Entities:  

Mesh:

Year:  2010        PMID: 20559845     DOI: 10.1007/s00415-010-5618-0

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  11 in total

1.  Pathological features of glycogen storage disease type II highlighted in the knockout mouse model.

Authors:  A G Bijvoet; H Van Hirtum; M Vermey; D Van Leenen; A T Van Der Ploeg; W J Mooi; A J Reuser
Journal:  J Pathol       Date:  1999-11       Impact factor: 7.996

2.  The pattern of involvement of adult-onset acid maltase deficiency at autopsy.

Authors:  J D van der Walt; M Swash; J Leake; E L Cox
Journal:  Muscle Nerve       Date:  1987 Mar-Apr       Impact factor: 3.217

3.  Aneurysms and vacuolar degeneration of cerebral arteries in late-onset acid maltase deficiency.

Authors:  H A Kretzschmar; H Wagner; G Hübner; A Danek; T N Witt; P Mehraein
Journal:  J Neurol Sci       Date:  1990-09       Impact factor: 3.181

4.  Alpha-glucosidase deficiency and basilar artery aneurysm: report of a sibship.

Authors:  M M Makos; R D McComb; M N Hart; D R Bennett
Journal:  Ann Neurol       Date:  1987-11       Impact factor: 10.422

5.  Recombinant human acid [alpha]-glucosidase: major clinical benefits in infantile-onset Pompe disease.

Authors:  P S Kishnani; D Corzo; M Nicolino; B Byrne; H Mandel; W L Hwu; N Leslie; J Levine; C Spencer; M McDonald; J Li; J Dumontier; M Halberthal; Y H Chien; R Hopkin; S Vijayaraghavan; D Gruskin; D Bartholomew; A van der Ploeg; J P Clancy; R Parini; G Morin; M Beck; G S De la Gastine; M Jokic; B Thurberg; S Richards; D Bali; M Davison; M A Worden; Y T Chen; J E Wraith
Journal:  Neurology       Date:  2006-12-06       Impact factor: 9.910

6.  Increased aortic stiffness in glycogenosis type 2 (Pompe's disease).

Authors:  Attila Nemes; Osama I I Soliman; Marcel L Geleijnse; Ashraf M Anwar; Nadine A M E van der Beek; Pieter A van Doorn; Henriette Gavallér; Eva Csajbók; Folkert J ten Cate
Journal:  Int J Cardiol       Date:  2006-11-03       Impact factor: 4.164

Review 7.  Management and treatment of glycogenosis type II.

Authors:  B Bembi; E Cerini; C Danesino; M A Donati; S Gasperini; L Morandi; O Musumeci; G Parenti; S Ravaglia; F Seidita; A Toscano; A Vianello
Journal:  Neurology       Date:  2008-12-02       Impact factor: 9.910

8.  Dilative arteriopathy and basilar artery dolichoectasia complicating late-onset Pompe disease.

Authors:  P Laforêt; P Petiot; M Nicolino; D Orlikowski; C Caillaud; N Pellegrini; R Froissart; T Petitjean; I Maire; H Chabriat; L Hadrane; D Annane; B Eymard
Journal:  Neurology       Date:  2008-05-27       Impact factor: 9.910

9.  Adult-onset acid maltase deficiency in siblings.

Authors:  Y Miyamoto; Y Etoh; R Joh; K Noda; I Ohya; M Morimatsu
Journal:  Acta Pathol Jpn       Date:  1985-11

10.  Mutation profile of the GAA gene in 40 Italian patients with late onset glycogen storage disease type II.

Authors:  A L E Montalvo; B Bembi; M Donnarumma; M Filocamo; G Parenti; M Rossi; L Merlini; E Buratti; P De Filippi; A Dardis; M Stroppiano; G Ciana; M G Pittis
Journal:  Hum Mutat       Date:  2006-10       Impact factor: 4.878

View more
  29 in total

1.  Urge incontinence and gastrointestinal symptoms in adult patients with pompe disease: a cross-sectional survey.

Authors:  Nesrin Karabul; Anika Skudlarek; Janine Berndt; Cornelia Kornblum; Rudolf A Kley; Stephan Wenninger; Nikolaus Tiling; Eugen Mengel; Ursula Plöckinger; Matthias Vorgerd; Marcus Deschauer; Benedikt Schoser; Frank Hanisch
Journal:  JIMD Rep       Date:  2014-08-26

2.  Hallucinations associated with miglitol use in a patient with chronic kidney disease and hypothyroidism.

Authors:  George Chinedu Ezeji; Taiga Inoue; Gul Bahtiyar; Alan Sacerdote
Journal:  BMJ Case Rep       Date:  2015-02-09

Review 3.  [Diagnosis and therapy of late onset Pompe disease].

Authors:  A Schüller; C Kornblum; M Deschauer; M Vorgerd; B Schrank; E Mengel; Z Lukacs; D Gläser; P Young; U Plöckinger; B Schoser
Journal:  Nervenarzt       Date:  2013-12       Impact factor: 1.214

4.  Pompe disease presenting as an isolated generalized dilative arteriopathy with repeated brain and kidney infarcts.

Authors:  Véronique Quenardelle; Marc Bataillard; Dorothée Bazin; Béatrice Lannes; Valérie Wolff; Andoni Echaniz-Laguna
Journal:  J Neurol       Date:  2014-12-02       Impact factor: 4.849

5.  Diffuse cerebral microhemorrhages in a patient with adult-onset Pompe's disease: a case report.

Authors:  Divyajot Sandhu; Adam Rizvi; Jae Kim; Rwoof Reshi
Journal:  J Vasc Interv Neurol       Date:  2014-12

6.  Postmortem Findings and Clinical Correlates in Individuals with Infantile-Onset Pompe Disease.

Authors:  Loren D M Pena; Alan D Proia; Priya S Kishnani
Journal:  JIMD Rep       Date:  2015-03-13

7.  Long term follow-up of cerebrovascular abnormalities in late onset Pompe disease (LOPD).

Authors:  Matteo Garibaldi; Sabrina Sacconi; Giovanni Antonini; Claude Desnuelle
Journal:  J Neurol       Date:  2017-01-24       Impact factor: 4.849

Review 8.  Extended phenotype description and new molecular findings in late onset glycogen storage disease type II: a northern Italy population study and review of the literature.

Authors:  Gauthier Remiche; Dario Ronchi; Francesca Magri; Costanza Lamperti; Andreina Bordoni; Maurizio Moggio; Nereo Bresolin; Giacomo P Comi
Journal:  J Neurol       Date:  2013-10-25       Impact factor: 4.849

9.  Late-onset Pompe disease: a genetic-radiological correlation on cerebral vascular anomalies.

Authors:  A Pichiecchio; S Sacco; P De Filippi; E Caverzasi; S Ravaglia; S Bastianello; C Danesino
Journal:  J Neurol       Date:  2017-08-30       Impact factor: 4.849

10.  Safety of Intradiaphragmatic Delivery of Adeno-Associated Virus-Mediated Alpha-Glucosidase (rAAV1-CMV-hGAA) Gene Therapy in Children Affected by Pompe Disease.

Authors:  Manuela Corti; Cristina Liberati; Barbara K Smith; Lee Ann Lawson; Ibrahim S Tuna; Thomas J Conlon; Kirsten E Coleman; Saleem Islam; Roland W Herzog; David D Fuller; Shelley W Collins; Barry J Byrne
Journal:  Hum Gene Ther Clin Dev       Date:  2017-12       Impact factor: 5.032

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.